Oxytocin and prolactin release after hypertonic saline administration in melatonin-treated male Syrian hamsters.
The aim of the present investigations was to examine the effects of melatonin (Mel) on oxytocin (OT) release under conditions of osmotic stimulation, brought about by hypertonic saline administration, as well as to determine whether osmotically stimulated OT release in Mel-treated Syrian hamster is associated with alterations in the release of prolactin (PRL) and in norepinephrine (NE) and dopamine (DA) content in the hypothalamus. In both Mel- and vehicle-treated hamsters, injection of hypertonic saline was followed by a significant decrease in OT content in the pituitary neurointermediate lobe (NIL) and elevation of plasma OT and PRL levels. Melatonin injections had no significant affect on NIL OT content in either isotonic- or hypertonic-saline treated animals. Pretreatment with Mel did not alter plasma OT or PRL levels in isotonic saline-injected animals. However, Mel facilitated the release of OT, but prevented the release of PRL after hypertonic saline administration. Melatonin treatment reduced hypothalamic NE content (but not that of DA) in isotonic-saline treated animals. After osmotic stimulation, hypothalamic content of NE and DA was significantly lower in Mel-treated than in vehicle-treated animals. Data from the present study suggest that the osmotically-stimulated release of OT and PRL seems to be related to the activation of noradrenergic rather than dopaminergic transmission. Both dopaminergic and noradrenergic transmission may be, however, involved in mediating the effects of Mel on the osmotically-activated OT and PRL release.
Juszczak
M
M
Department of Physiology, Southern Illinois University School of Medicine, Carbondale, USA.
Steger
R W
RW
Fadden
C
C
Bartke
A
A
D000704:Analysis of Variance; D000818:Animals; D006224:Cricetinae; D004298:Dopamine / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D008550:Melatonin / Q000494:pharmacology*; D008647:Mesocricetus; D009638:Norepinephrine / Q000378:metabolism; D010121:Oxytocin / Q000097:blood / Q000378:metabolism*; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage
D012462:Saline Solution, Hypertonic; D010121:Oxytocin; D011388:Prolactin; D008550:Melatonin; D004298:Dopamine; D009638:Norepinephrine